drugset / Trial / NCT01469988

The VO2 Increase With Testosterone Addition - Heart Failure (VITA-HF) Trial

NCT01469988

Phase 2 Terminated 318 enrolled University of Alberta
RandomizedSingle-groupDouble-blindTreatment

Summary

Evaluate the efficacy and safety of testosterone supplementation on functional capacity, biomarkers, quality of life and clinical outcomes for patients with heart failure.

Timeline

Start
2012-11
Primary completion
2014-04
Completion
2014-04

Drugs

EvaluationDrugModalityDoseRoute
Subject Testosterone Small molecule 0.3 g
Subject Testosterone Small molecule 5 g

Indications